

Some Cambodian P vivax parasites clear slowly after artesunate treatment, possibly due to a downregulation of haemoglobin metabolism that might reduce the efficiency of the artesunate. The slow clearance could allow parasites to outlast artesunate treatment and facilitate emergence of resistance to the artemisinin-combination therapy partner drug, threatening malaria elimination effort.
Microbe / Infectious Research
|11th Mar, 2026
|The Lancet
Microbe / Infectious Research
|11th Mar, 2026
|The Lancet
Microbe / Infectious Research
|11th Mar, 2026
|The Lancet
Microbe / Infectious Research
|11th Mar, 2026
|The Lancet
Microbe / Infectious Research
|11th Mar, 2026
|The Lancet
Microbe / Infectious Research
|11th Mar, 2026
|The Lancet
Microbe / Infectious Research
|11th Mar, 2026
|The Lancet